Clinical Trial Portfolios: A Critical Oversight in Human Research Ethics, Drug Regulation, and Policy
Abstract
Regulators rely on clinical trials for drug approval and labeling decisions. Health systems and clinicians rely on the evidence from trials to determine treatment, and patients rely on it to decide which courses of care to undertake. Many of these stakeholders presume that the careful review of individual studies is enough to address the ethical and scientific questions that arise in clinical trials. In what follows, however, we demonstrate that...
Paper Details
Title
Clinical Trial Portfolios: A Critical Oversight in Human Research Ethics, Drug Regulation, and Policy
Published Date
Jul 1, 2019
Journal
Volume
49
Issue
4
Pages
31 - 41
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History